BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2012
View Archived Issues
Discovery of small-molecule, brain-penetrable agents for Parkinson's disease
Read More
L-Arginine evaluated in severe falciparum malaria
Read More
Kyowa Hakko Kirin patents novel calcium channel ligands
Read More
Achaogen discloses new agents for Gram-negative bacterial infections
Read More
Lilly stops one of three phase III tabalumab trials in rheumatoid arthritis
Read More
Phase I trial of MM-141 commences in advanced solid tumors
Read More
Encouraging data reported from phase III study of Reolysin in head and neck cancers
Read More
Gilead Sciences signs definitive agreement to acquire YM BioSciences
Read More
ArQule treats first patient in phase I trial of ARQ-087
Read More
First patient dosed in phase II galeterone trial
Read More
Eisai and UCL partner to develop new treatments for neurological diseases
Read More
FDA accepts NDA for Pfizer and Ligand's BZA/CE
Read More
Targeted delivery of proteins across BBB disclosed by U.S. team
Read More
Roche presents novel hormone-sensitive lipase inhibitors
Read More
Researchers at Roche disclose new protein kinase inhibitors
Read More
Bionomics and Merck KGaA present new potassium channel blockers
Read More
Bay-846, a potential new treatment for malignant brain tumors
Read More
AXL inhibitors show efficacy in leukemia
Read More
Bionomics nominates new candidate for treatment of Alzheimer's disease
Read More
Novel inhibitor of IDH1/2 shows therapeutic potential in the treatment of AML
Read More
Japanese researchers present novel biomarkers of sublingual immune therapy
Read More
FDA approves GSK's raxibacumab for inhalational anthrax
Read More
Novel class of compounds discovered to overcome antibacterial resistance
Read More
Biotron's BIT-225 completes proof-of-concept trial in HIV
Read More
EMA committee adopts negative opinion on MAA for Kynamro in HoFH
Read More
Vanda's Fanaptum receives negative opinion from EMA
Read More
EMA committee recommends approval of Selincro for alcohol dependence
Read More
FDA approves Novartis' Signifor for treatment of Cushing's disease
Read More